two carbohydrate-phosphoric acid solutions , one a widely used beverage ( solution c ) and the other a pharmaceutical product used as an antiemetic ( solution e ) , administered together with riboflavin-5'-phosphate or salicylamide to healthy human adults , significantly increased the bioavailability of riboflavin and appreciably altered the metabolic fate of salicylamide ( increased conversion to the sulfate and decreased formation of the glucuronide ) .
C0016388
riboflavin-5
C0035527
riboflavin